The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1β

Autor: Khajah, Maitham A., Hawai, Sanaa, Szollosi, Doreen E., Bill, Ashley, Ghoneim, Ola, Edafiogho, Ivan
Zdroj: In Biomedicine & Pharmacotherapy September 2021 141
Databáze: ScienceDirect